BACKGROUND
The immaturity of the immune system in early life renders infants vulnerable to infectious diseases, particularly those of the gastrointestinal and respiratory tracts. According to the World Health Organization, acute lower respiratory tract infections are the leading cause of death and hospitalization in children globally (1) . How the immune system matures in early life is not fully understood. A better understanding of the nature of the immune and inflammatory response to infection in infants and why some infants develop disease could help to identify new clinical biomarkers, treatments, and prophylactics.
One of the major hurdles in the field of neonatal and pediatric immunology is obtaining relevant samples, which is limited by ethical restrictions on the volume and number of samples that can be taken. As a result, much of our understanding of cellular immunity in infants comes from studies of umbilical cord blood. Less is known about immunity in more mature infants, and less still is known about immunity to infection at mucosal sites, such as the lung (2) (3) (4) . Moreover, the use of invasive procedures to obtain, for example, lower airway samples cannot be justified in healthy infants. It is important, therefore, that techniques are developed that facilitate the characterization of the immune response in small-volume and paucicellular samples, particularly from sites of infection where sampling is limited. In designing this OMIP (5) we focused on developing a panel to enumerate the innate lymphoid cell (ILC), granulocyte and T-cell responses in infants, particularly those with a lung infection (Table 1) . To reflect the challenging situation of limited amounts of blood and airway samples from infants we optimized this panel using a small volume (300 μl) of adult peripheral blood. Pitoiset et al. (2018) were able to detect regulatory T cells (Tregs) in as little as 60 μl of whole blood from children (6) and others have demonstrated the feasibility of detecting T cell subsets and Type 2 ILCs within pediatric airway samples (7, 8) .
The recently discovered ILCs have been implicated in playing a pivotal role in immune responses to viral and bacterial pathogens, and they are particularly abundant at mucosal sites (9) (10) (11) . There are three main subsets of ILC; ILC1s, ILC2s, and ILC3s, which may mirror CD4 + T helper 1 (Th1), Th2, and Th17 subsets, whereas NK cells may complement the cytokine profile and function of CD8 + T cells (12) . ILCs comprise only 0.1 to 0.01% of lymphocytes in adult blood (13) and most published methods for detection of ILCs are optimized on relatively large volumes of peripheral blood, however, since ILCs are relatively abundant in children we anticipated relatively high frequencies in small volume pediatric samples (8, 14, 15) . Immunophenotyping ILCs can be challenging as they are defined as lineage negative lymphocytes, which lack specific markers, including CD3 (T cells), CD19 (B cells), CD34 (progenitor cells), FcεR1α (mast cells) and CD1a, CD123, BDCA2 (plasmacytoid dendritic cells, pDC) (15, 16) . Accordingly, while designing this panel we made sure that a very stringent gating strategy was utilized to obtain a pure ILC subset. We used biaxial gating to delineate ILCs as lineage negative, CD127 (IL-7 receptor-α) positive, live lymphocytes. We distinguished ILC subsets using surface expression of prostaglandin D 2 receptor chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) and CD117 (c-Kit) (8, 10, 17) . In designing this OMIP other components of the cellular immune response were included, which gives this panel broad applicability to other pediatric clinical studies. These were myeloid cells (neutrophils, eosinophils), invariant T cells (mucosal invariant T cells (MAITs) and NKT-like cells) and adaptive T cells (CD4 + and CD8 + ). By immunophenotyping whole blood, rather than peripheral blood mononuclear cells (PBMC), we reduced the processing time and retained granulocyte populations. All fluorochrome-conjugated antibodies were titrated during panel optimization and are listed in Table 2 .
Cells were delineated using the following gating strategy: FSC/SSC, single cells, live cells. Granulocytes, monocytes, and lymphocytes were gated using FSC and the CD45 cell marker ( Fig. 1A) . Within the granulocyte population, neutrophils were defined as CD16 H CD66b +/− and eosinophils as CD16 +/-CD66b + (Fig. 1B) . Within the lymphocyte gate, the markers CD56 and CD3 were used to identify NK cells (CD56 + CD3 − ), conventional T lymphocytes (CD3 + CD56 − ) and NKT-like cells (CD56 + CD3 + ) ( Fig. 1D) (18) (19) (20) . NK cells were further subdivided into CD56 H CD16 L and CD56 L CD16 H populations according to the CD56 and CD16 density (Fig. 1E ). T lymphocytes (CD3 + CD56 − ) were segregated into CD4 + or CD8 + T cells (Fig. 1H ). Th2 and Tc2 cells were defined within the CD4 + and CD8 + T cell subsets, respectively, using the CRTH2 surface marker, as these Type-2 cytokine-producing cells express high levels of CRTH2 (8,21) ( Fig. 1F,G) . Within CD8 + T cells, we also identified MAIT cells. MAIT cells are invariant T lymphocytes which respond to riboflavin metabolites in the context of the MHC class I related molecule MR1 (22, 23) . MAIT cells were identified within the CD3 + CD56 − CD8 + gate as CD161 H Vα7.2 + cells (Fig. 1I ). NKT cells are conventionally described as CD3 + CD56 + lymphocytes (24, 25) , however, the use of these markers alone defines a heterogeneous population of lymphocytes, which we designate here as "NKT-like" cells. CD56 can be expressed by many CD3 + lymphocyte subpopulations, including invariant NKT cells (iNKT cells), and some γδ T cells and MAIT cells (which have previously been described as mucosal NKT cells) (26, 27) . Strategies to define these subpopulations are discussed further in the Supporting Information (Part B). Finally, ILCs were defined using the following gating strategy: live, single, CD45 + lymphocytes, lineage (CD3, CD56, CD14, CD19, CD123, FcεR1α) negative, and CD127 + cells (Fig. 1C) ; ILC1s were defined as CD117 − CRTH2 − , ILC2s as CRTH2 + CD117 int , and ILC3s as CD117 + CRTH2 − (15, 28) . To further analyze different populations of cells in this OMIP, unbiased high dimensional stoichiometry (t-SNE) analysis was performed on live, single, CD45 + cells incorporating the lymphocyte, granulocyte, and monocyte gates (Fig. 1J ). In this example, t-SNE not only revealed that all the populations of cells segregated according to the gating strategy illustrated in Figure 1A -I but additionally discriminated distinct or poorly defined populations. Therefore, this 14-color flow panel can be used to delineate other unknown populations using high-dimensional data visualization techniques (29) .
Following optimization on adult peripheral blood, we confirmed that the panel was suitable for staining umbilical cord blood, and peripheral blood, tracheal aspirate, and nasal aspirate samples from infants. The inclusion of CD45 in the panel allowed us to separate leukocytes from structural cells, such as epithelial cells, found in airway samples. Concentrations of antibodies were kept the same for analysis of different samples as they gave the same optimal separation between positive and negative populations; however, the protocol for staining airway samples was more methodically complicated and included the use of Fc block. Counting beads were included to allow absolute counts of cell numbers. Detailed information on the panel development and optimization can be found in the Supporting Information (Part B).
HUMAN SAMPLES
All blood and airway samples were collected from subjects after gaining written consent. Some samples were collected as a part of the Early Life Lung Infection (ELLI) and RSV-SAM studies, 
